CNS Pharmaceuticals (NASDAQ:CNSP) Trading Down 3.7%
Shares of CNS Pharmaceuticals Inc (NASDAQ:CNSP) fell 3.7% during mid-day trading on Tuesday . The company traded as low as $4.40 and last traded at $4.42, 3,042 shares traded hands during trading. A decline of 95% from the average session volume of 64,179 shares. The stock had previously closed at $4.59.
Separately, Benchmark assumed coverage on CNS Pharmaceuticals in a report on Wednesday, December 4th. They set a “speculative buy” rating for the company.
The business has a 50 day simple moving average of $4.07.
About CNS Pharmaceuticals (NASDAQ:CNSP)
CNS Pharmaceuticals, Inc, a preclinical stage pharmaceutical company, focuses on the development of anti-cancer drug candidates for the treatment of primary and metastatic brain, and central nervous system tumors. Its lead drug candi ...